Referenties
1Arroyo R, Massana M, Vila C. Correlation between spasticity and quality of life in patients with multiple sclerosis: the CANDLE study. Int J Neurosci. 2013 Dec;123(12):850-8.
2Alonso J, Regidor E, Barrio G, Prieto L, Rodríguez C, de la Fuente L. Population reference values of the Spanish version of the Health Questionnaire SF-36. Med Clin (Barc). 1998 Oct 10;111(11):410-6. In the absence of normative SF-12 data, normative SF-36 data from a Spanish population is used here as an approximate comparison.
3Bose, P, Hou J, and Thompson FJ. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Chapter 14 Traumatic Brain Injury (TBI)-Induced Spasticity Neurobiology, Treatment, and Rehabilitation (2015) Taylor & Francis Group, LLC. PMID: 26269896.
4Hoving MA, van Raak EP, Spincemaille GH, et al; Dutch Study Group on Child Spasticity. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy. Eur J Paediatr Neurol. 2009;13(3):247-256
5Van der Meer P, Post MW, van Leeuwen CM, van Kuppevelt HJ, Smit CA, van Asbeck FW. Impact of health problems secondary to SCI one and five years after first inpatient rehabilitation. Spinal Cord. 2017 Jan;55(1):98-104. doi: 10.1038/sc.2016.103. Epub 2016 Jul 19
6Welmer et al. Spasticity and Its association with functioning and health-related quality of life 18 months after stroke. Cerebrovasc Dis 2006;21:247–53.
8WebMD Pain Management Health Center. Pain Management: Spasticity. Beschikbaar op: www.webmd.com. Bekeken in juli 2017
9Furr-Stimming E, Boyle AM, Schiess MC. Spasticity and intrathecal baclofen. Semin Neurol. 2014 Nov;34(5):591-6.